Potent and selective HIV-1 protease inhibitor (EC50 = 6.5 nM, against HIV cultured in peripheral blood mononuclear cells.
More potent at inhibiting HIV-1 than ritonavir in vitro but shows poor bioavailability in vivo.
Shows antiviral effect against SARS-CoV, MERS-CoV, and hCoV-229E in vitro, (mean EC50 ranged from 6.6 to 17.1µM).
Inhibits SARS-CoV-2 replication in vitro in Vero E6 cells (EC50 = < 100µM).
Also acts as a potent ER stress inducer.
Solubility & Handling
Solubility overview
Soluble in DMSO (100 mM), and in ethanol (100 mM)
Storage instructions
-20°C
Storage of solutions
Prepare and use solutions on the same day if possible. Store solutions at -20°C for up to one month if storage is required. Equilibrate to RT and ensure the solution is precipitate free before use.
Shipping Conditions
Stable for ambient temperature shipping. Follow storage instructions on receipt.
Important
This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use
In vitro selection and characterization of human immunodeficiency virus type 1 variants with increased resistance to ABT-378, a novel protease inhibitor